Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
78.05
+0.40 (0.52%)
At close: Dec 5, 2025
50.39%
Market Cap 35.83B
Revenue (ttm) 6.88B
Net Income (ttm) 1.14B
Shares Out n/a
EPS (ttm) 3.13
PE Ratio 31.56
Forward PE 24.03
Dividend 1.20 (1.55%)
Ex-Dividend Date Jun 25, 2025
Volume 115,000
Average Volume 201,492
Open 77.75
Previous Close 77.65
Day's Range 76.35 - 78.60
52-Week Range 39.95 - 116.60
Beta 0.30
RSI 41.81
Earnings Date Apr 1, 2026

About HKG:6821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 9,595
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6821
Full Company Profile

Financial Performance

In 2024, HKG:6821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.